Pierre Étienne - Concepedia

Author

Pierre Étienne

Also Known As

Etienne, P., Etienne, Pierre, P Etienne, P L Etienne, P. Etienne, P. L. Etienne, P.-L. Etienne, P.L Etienne, P.L. Etienne, Pierre Etienne

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Sorbonne Université Inserm Laboratoires Phodé (France)Université de Rennes Hôpital Saint-Antoine

PÉ

About

Pierre Étienne is an author at Sorbonne Université specializing in cancer therapeutics, oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	202
2	Health Sciences	4	4	127
3	Pathology	4	4	174
4	Pharmacology	4	4	188
5	Surgical Oncology	1	1	36

Pierre Étienne

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. Aimery de Gramont, J.-F. Bosset, C Milan, Journal of Clinical Oncology	1997	904
A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus É. Le Prisé, Pierre Étienne, Bernard Meunier, Cancer	1994	620
Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803 Olivier Bouché, Jean‐Luc Raoul, Franck Bonnetain, Journal of Clinical Oncology	2004	278
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival Thierry Conroy, Pierre Étienne, Antoine Adenis, Annals of Oncology OncologyEsophageal CancerGastrointestinal OncologyMedicineCancer Management	2002	75
Hydrophobins, beer foaming and gushing Zahra Shokribousjein, Sylvie Deckers, Kurt Gebruers, Cerevisia Beer FoamingFoamHigh Hydrostatic Pressure	2011	64
OPTIMOX study: FOLFOX 7/LV5FU2 compared to FOLFOX 4 in patients with advanced colorectal cancer Armand de Gramont, Andrés Cervantes, Thierry André, Journal of Clinical Oncology PathologyPharmacotherapyArm A Folfox4Advanced Colorectal CancerArm B	2004	49
Randomized strategical trial of chemotherapy in metastatic colorectal cancer (FFCD 2000–05): Preliminary results Olivier Bouché, Marine Castaing, Pierre Étienne, Journal of Clinical Oncology Surgical OncologyPathologySurgeryPharmacotherapyOncology	2007	36
Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer M. Namer, P. Soler-Michel, F Turpin, European Journal of Cancer Metastatic Breast CancerBreast OncologyMedicinePharmacologyPhase Iii Prospective	2001	28
Validation of a Psychosocial Chronic Stress Model in the Pig Using a Multidisciplinary Approach at the Gut-Brain and Behavior Levels Sophie Menneson, Samuel Ménicot, Stéphanie Ferret‐Bernard, Frontiers in Behavioral Neuroscience	2019	28
Pharmacokinetic and antimicrobial activity of a new carvacrol-based product against a human pathogen,<i>Campylobacter jejuni</i> Marion Allaoua, Pierre Étienne, V. Noirot, Journal of Applied Microbiology	2018	18

Page 1